MedPath

Application of Cervical Elastography in Obstetrics

Completed
Conditions
Cervical Elastography
Interventions
Device: Samsung's E-cervix technology
Registration Number
NCT03902587
Lead Sponsor
NYU Langone Health
Brief Summary

The purpose of this study is to develop cervical elastography nomograms using Samsung's novel technology "E-cervix" and determine its ability to predict preterm birth.

During each sonogram in which cervical lengths are measured, 5 additional cervical indices will be collected using Samsung's E-cervix technology. Each index will then be separated based on characteristics to create a nomogram for singletons, twins, and those with interventions already in place (i.e. cerclage and/or progesterone) at the time of their E-cervix assessment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1000
Inclusion Criteria
  • Women who present for early screening or level II ultrasound, aged 18 to 50 years, provides written Informed consent and is willing to comply with protocol requirements, and obtained cervical length and measurements using the E-cervix software/hardware
Read More
Exclusion Criteria
  • >50 years old
  • prior cervical surgical procedures (i.e. LEEP procedure, cold knife cone biopsy)
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cervical ElastographySamsung's E-cervix technologyDuring each sonogram in which cervical lengths are measured, 5 additional cervical indices will be collected using Samsung's E-cervix technology. Each index will then be separated based on characteristics to create a nomogram for singletons, twins, and those with interventions already in place (i.e. cerclage and/or progesterone) at the time of their E-cervix assessment.
Primary Outcome Measures
NameTimeMethod
Number of preterm Births24 Months
Secondary Outcome Measures
NameTimeMethod
E-cervix indices18 Weeks, 19 Weeks, 20 Weeks, 21 Weeks, 22 Weeks

Pearson or Spearman correlation coefficients will be calculated to determine the association between the cervical length and each of the e-cervix parameters at the baseline assessment at 18-22 weeks.

Trial Locations

Locations (1)

NYU Winthrop Hospital

🇺🇸

Mineola, New York, United States

© Copyright 2025. All Rights Reserved by MedPath